Comments on: Routine Use of Axicabtagene Ciloleucel Could Be Cost Effective in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Comments on: Routine Use of Axicabtagene Ciloleucel Could Be Cost Effective in Relapsed/Refractory Diffuse Large B-Cell Lymphoma https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/lymphoma-axicabtagene-ciloleucel-routine-use-cost-effective-cart-therapy-risk/ Sat, 14 Oct 2023 02:45:41 +0000 hourly 1 https://wordpress.org/?v=6.4.3